loadpatents
Patent applications and USPTO patent grants for Yaguchi; Tomonori.The latest application filed is for "therapeutic agent for cancer".
Patent | Date |
---|---|
Anti-glypican-1-immunizing antigen receptor Grant 11,370,845 - Yaguchi , et al. June 28, 2 | 2022-06-28 |
Therapeutic Agent For Cancer App 20210023025 - KAWAKAMI; Yutaka ;   et al. | 2021-01-28 |
Medicament For Cancer Treatment App 20200376029 - Kato; Daiki ;   et al. | 2020-12-03 |
Formulation of curcumin and anti-PD-1 antibody Grant 10,849,862 - Kawakami , et al. December 1, 2 | 2020-12-01 |
Anti-glypican-1-immunizing Antigen Receptor App 20180230230 - Yaguchi; Tomonori ;   et al. | 2018-08-16 |
Therapeutic Agent For Cancer App 20170367997 - KAWAKAMI; Yutaka ;   et al. | 2017-12-28 |
Diagnostic Marker For Melanoma, Pharmaceutical Composition Comprising Inhibitor Of The Function Of The Histatin-1 Protein And Immunosuppressor App 20130273653 - Yaguchi; Tomonori ;   et al. | 2013-10-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.